Ozempic for All?
The Daily14 Marras 2025

Ozempic for All?

Drugs like Ozempic and Zepbound have revolutionized weight loss. And starting next year, the drugs are going to become more affordable for Americans because of a deal struck with pharmaceutical companies by the Trump administration.

Eshe Nelson, who covers economics and business news, explains how the change has its origins in a huge business blunder from the creator of Ozempic, Novo Nordisk.

Guest: Eshe Nelson, a reporter for The New York Times based in London, where she covers economics and business news.

Background reading:

Photo: Sergei Gapon/Agence France-Presse — Getty Images

For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.

Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Jaksot(2782)

Suosittua kategoriassa Politiikka ja uutiset

aikalisa
ootsa-kuullut-tasta-2
politiikan-puskaradio
tervo-halme
rss-ootsa-kuullut-tasta
viisupodi
rss-vaalirankkurit-podcast
rss-podme-livebox
rss-asiastudio
otetaan-yhdet
the-ulkopolitist
et-sa-noin-voi-sanoo-esittaa
rss-tasta-on-kyse-ivan-puopolo-verkkouutiset
rss-kaikki-uusiksi
rss-hyvaa-huomenta-bryssel
rss-kiina-ilmiot
linda-maria
rikosmyytit
radio-antro
rss-polikulaari-pitka-kiekko-ja-muut-ts-podcastit